{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:18:13Z","timestamp":1778681893156,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2017MH060"],"award-info":[{"award-number":["ZR2017MH060"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key R & D Plan of Shandong Province","award":["2018GSF118049"],"award-info":[{"award-number":["2018GSF118049"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00418-020-01877-7","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T03:11:52Z","timestamp":1593486712000},"page":"215-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition"],"prefix":"10.1007","volume":"154","author":[{"given":"Zhi","family":"Jiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"1877_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C et al (2015) Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385:977\u20131010. https:\/\/doi.org\/10.1016\/S0140-6736(14)62038-9","journal-title":"Lancet"},{"key":"1877_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1568009617666170427103732","volume":"18","author":"J Barroca-Ferreira","year":"2018","unstructured":"Barroca-Ferreira J et al (2018) Targeting STEAP1 protein in human cancer: current trends and future challenges. Curr Cancer Drug Targets 18:222\u2013230. https:\/\/doi.org\/10.2174\/1568009617666170427103732","journal-title":"Curr Cancer Drug Targets"},{"key":"1877_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"1877_CR4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.222844","author":"JA Carrasquillo","year":"2019","unstructured":"Carrasquillo JA et al (2019) Imaging metastatic castration-resistant prostate cancer patients with89 Zr-DFO-MSTP2109A anti-STEAP1 antibody. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.118.222844","journal-title":"J Nucl Med"},{"key":"1877_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331:1559\u20131564. https:\/\/doi.org\/10.1126\/science.1203543","journal-title":"Science"},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1158\/0008-5472.can-06-3849","volume":"67","author":"PM Challita-Eid","year":"2007","unstructured":"Challita-Eid PM et al (2007) Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumour xenografts in vivo. Cancer Res 67:5798\u20135805. https:\/\/doi.org\/10.1158\/0008-5472.can-06-3849","journal-title":"Cancer Res"},{"key":"1877_CR7","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.biopha.2019.01.012","volume":"111","author":"X Chen","year":"2019","unstructured":"Chen X, Wang R, Chen A, Wang Y, Wang Y, Zhou J, Cao R (2019) Inhibition of mouse RM-1 prostate cancer and B16F10 melanoma by the fusion protein of HSP65 and STEAP1 186-193. Biomed Pharmacother 111:1124\u20131131. https:\/\/doi.org\/10.1016\/j.biopha.2019.01.012","journal-title":"Biomed Pharmacother"},{"key":"1877_CR8","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1158\/1078-0432.ccr-07-1417","volume":"13","author":"IY Cheung","year":"2007","unstructured":"Cheung IY, Feng Y, Danis K, Shukla N, Meyers P, Ladanyi M, Cheung NKV (2007) Novel markers of subclinical disease for ewing family tumours from gene expression profiling. Clin Cancer Res 13:6978\u20136983. https:\/\/doi.org\/10.1158\/1078-0432.ccr-07-1417","journal-title":"Clin Cancer Res"},{"key":"1877_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13:97\u2013110. https:\/\/doi.org\/10.1038\/nrc3447","journal-title":"Nat Rev Cancer"},{"key":"1877_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20:69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1021\/acs.molpharmaceut.9b00326","volume":"16","author":"JA O Donoghue","year":"2019","unstructured":"O Donoghue JA et al (2019) Pharmacokinetics and biodistribution of a [89 Zr]Zr-DFO-MSTP2109A anti-STEAP1 antibody in metastatic castration-resistant prostate cancer patients. Mol Pharm 16:3083\u20133090. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00326","journal-title":"Mol Pharm"},{"key":"1877_CR12","doi-asserted-by":"publisher","unstructured":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016 (2017). Lancet 390:1151\u20131210. https:\/\/doi.org\/10.1016\/S0140-6736(17)32152-9","DOI":"10.1016\/S0140-6736(17)32152-9"},{"key":"1877_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12032-018-1100-0","volume":"35","author":"IM Gomes","year":"2018","unstructured":"Gomes IM, Rocha SM, Gaspar C, Alvelos MI, Santos CR, Socorro S, Maia CJ (2018) Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens. Med Oncol 35:40. https:\/\/doi.org\/10.1007\/s12032-018-1100-0","journal-title":"Med Oncol"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbcan.2017.06.006","volume":"1868","author":"S Goossens","year":"2017","unstructured":"Goossens S, Vandamme N, Van Vlierberghe P, Berx G (2017) EMT transcription factors in cancer development re-evaluated: beyond EMT and MET. Biochim Biophys Acta Rev Cancer 1868:584\u2013591. https:\/\/doi.org\/10.1016\/j.bbcan.2017.06.006","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1158\/1541-7786.mcr-11-0524","volume":"10","author":"TGP Grunewald","year":"2012","unstructured":"Grunewald TGP et al (2012a) STEAP1 is associated with the invasive and oxidative stress phenotype of ewing tumors. Mol Cancer Res 10:52\u201365. https:\/\/doi.org\/10.1158\/1541-7786.mcr-11-0524","journal-title":"Mol Cancer Res"},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/annonc\/mdr605","volume":"23","author":"TGP Grunewald","year":"2012","unstructured":"Grunewald TGP et al (2012b) High STEAP1 expression is associated with improved outcome of Ewing\u2019s sarcoma patients. Ann Oncol 23:2185\u20132190. https:\/\/doi.org\/10.1093\/annonc\/mdr605","journal-title":"Ann Oncol"},{"key":"1877_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"1877_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1479-5876-9-191","volume":"9","author":"S Hayashi","year":"2011","unstructured":"Hayashi S et al (2011) Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer. J Transl Med 9:191. https:\/\/doi.org\/10.1186\/1479-5876-9-191","journal-title":"J Transl Med"},{"key":"1877_CR19","doi-asserted-by":"publisher","first-page":"14523","DOI":"10.1073\/pnas.96.25.14523","volume":"96","author":"RS Hubert","year":"1999","unstructured":"Hubert RS et al (1999) STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA 96:14523\u201314528. https:\/\/doi.org\/10.1073\/pnas.96.25.14523","journal-title":"Proc Natl Acad Sci USA"},{"key":"1877_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/his.12226","volume":"63","author":"SM Ihlaseh-Catalano","year":"2013","unstructured":"Ihlaseh-Catalano SM, Drigo SA, de Jesus CM, Domingues MA, Trindade Filho JC, de Camargo JL, Rogatto SR (2013) STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma. Histopathology 63:678\u2013685. https:\/\/doi.org\/10.1111\/his.12226","journal-title":"Histopathology"},{"key":"1877_CR21","volume-title":"WHO classification of tumours of female reproductive organs","year":"2014","unstructured":"Kurman RJ, Carcangiu LM, Herrington CS, Young RH (eds) (2014) WHO classification of tumours of female reproductive organs. IARC Press, Lyon"},{"key":"1877_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1877_CR23","doi-asserted-by":"publisher","first-page":"e592","DOI":"10.3390\/ijms17040592","volume":"17","author":"CH Lee","year":"2016","unstructured":"Lee CH et al (2016) The prognostic role of STEAP1 expression determined via immunohistochemistry staining in predicting prognosis of primary colorectal cancer: a survival analysis. Int J Mol Sci 17:e592. https:\/\/doi.org\/10.3390\/ijms17040592","journal-title":"Int J Mol Sci"},{"key":"1877_CR24","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/cancers11060838","volume":"11","author":"N Loret","year":"2019","unstructured":"Loret N, Denys H, Tummers P, Berx G (2019) The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance. Cancers 11:838. https:\/\/doi.org\/10.3390\/cancers11060838","journal-title":"Cancers"},{"key":"1877_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12020-008-9113-7","volume":"34","author":"CJB Maia","year":"2008","unstructured":"Maia CJB, Socorro S, Schmitt F, Santos CRA (2008) STEAP1 is over-expressed in breast cancer and down-regulated by 17\u03b2-estradiol in MCF-7 cells and in the rat mammary gland. Endocrine 34:108\u2013116. https:\/\/doi.org\/10.1007\/s12020-008-9113-7","journal-title":"Endocrine"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41417-018-0056-8","volume":"26","author":"H Nakamura","year":"2018","unstructured":"Nakamura H et al (2018) Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer. Cancer Gene Ther 26:313\u2013322. https:\/\/doi.org\/10.1038\/s41417-018-0056-8","journal-title":"Cancer Gene Ther"},{"key":"1877_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/0284186x.2011.653437","volume":"51","author":"W Oberaigner","year":"2012","unstructured":"Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, de Angelis R, Mangone L, Sant M (2012) Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade. Acta Oncol 51:441\u2013453. https:\/\/doi.org\/10.3109\/0284186x.2011.653437","journal-title":"Acta Oncol"},{"key":"1877_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ncb2976","volume":"16","author":"A Puisieux","year":"2014","unstructured":"Puisieux A, Brabletz T, Caramel J (2014) Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol 16:488\u2013494. https:\/\/doi.org\/10.1038\/ncb2976","journal-title":"Nat Cell Biol"},{"key":"1877_CR29","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1002\/jcb.28393","volume":"120","author":"J Sun","year":"2019","unstructured":"Sun J, Ji G, Xie J, Jiao Z, Zhang H, Chen J (2019) Six-transmembrane epithelial antigen of the prostate 1 is associated with tumour invasion and migration in endometrial carcinomas. J Cell Biochem 120:11172\u201311189. https:\/\/doi.org\/10.1002\/jcb.28393","journal-title":"J Cell Biochem"},{"key":"1877_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131\u2013142. https:\/\/doi.org\/10.1038\/nrm1835","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1877_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S et al (2011) Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11:719\u2013725. https:\/\/doi.org\/10.1038\/nrc3144","journal-title":"Nat Rev Cancer"},{"key":"1877_CR32","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3389\/fphys.2018.01132","volume":"9","author":"YY Wu","year":"2018","unstructured":"Wu YY, Jiang JN, Fang XD, Ji FJ (2018) STEAP1 regulates tumorigenesis and chemoresistance during peritoneal metastasis of gastric cancer. Front Physiol 9:1132. https:\/\/doi.org\/10.3389\/fphys.2018.01132","journal-title":"Front Physiol"},{"issue":"1","key":"1877_CR33","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.clbc.2018.08.010","volume":"19","author":"J Xie","year":"2019","unstructured":"Xie J, Yang Y, Sun J, Jiao Z, Zhang H, Chen J (2019) STEAP1 inhibits breast cancer metastasis and is associated with epithelial\u2013mesenchymal transition procession. Clinical Breast Cancer 19(1):e195\u2013e207. https:\/\/doi.org\/10.1016\/j.clbc.2018.08.010","journal-title":"Clinical Breast Cancer"},{"key":"1877_CR34","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.yexcr.2013.07.025","volume":"319","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T et al (2013) Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumour growth via intercellular communication. Exp Cell Res 319:2617\u20132626. https:\/\/doi.org\/10.1016\/j.yexcr.2013.07.025","journal-title":"Exp Cell Res"},{"key":"1877_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/bjc.2014.626","volume":"112","author":"X Zhuang","year":"2015","unstructured":"Zhuang X et al (2015) Identification of novel vascular targets in lung cancer. Br J Cancer 112:485\u2013494. https:\/\/doi.org\/10.1038\/bjc.2014.626","journal-title":"Br J Cancer"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-020-01877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00418-020-01877-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-020-01877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T23:42:40Z","timestamp":1620344560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00418-020-01877-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1007\/s00418-020-01877-7","relation":{},"ISSN":["0948-6143","1432-119X"],"issn-type":[{"value":"0948-6143","type":"print"},{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"2 April 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors in this study declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Ethics Committee of Human and Animal Institution of Shandong University. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained the\u00a0written informed consents of the patients involved in the study. All mouse experimental procedures were performed in accordance with the Regulations for the Administration of Affairs Concerning Experimental Animals approved by the State Council of the People\u2019s Republic of China.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}